Find and Pitch Jounalists, Get Your Story Covered

Tags: ViroCell GOSH MHRA manufacturing approval

	Profile	Recent Articles on Subject
1	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies - 28 days ago Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis - 3 months ago CellVoyant secures £7.6 million AI stem cell boost - about 1 year ago
2	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	A biotech’s race to tackle the most severe hepatitis - 3 months ago A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 7 months ago In a Duchenne market beset by problems, Capricor data marks a bright spot - 7 months ago Kyverna follows oncology’s CAR-T cell playbook for an ultra-rare autoimmune disorder - 8 months ago Is a better CAR-T cell therapy option on the horizon? - 8 months ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Startup Valora Unveils a Sweet Way to Stop Cancer and Autoimmune Disease, Plus $30M for R&D - 3 months ago Novartis to Pay $150M for Monte Rosa Glue Drug in the Clinic for Immunology Indications - 4 months ago Artiva’s IPO Reels In $167M to Bring NK Cell Therapy to Autoimmune Diseases - 8 months ago
4	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Pharma takes aim at a wily foe — the Epstein-Barr virus - 4 months ago After scoring a first for an off-the-shelf T cell therapy, can Atara maintain momentum? - 5 months ago Red Jacket: Helen Sabzevari, an immunotherapy pioneer - over 1 year ago
5	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - 4 months ago A plucky biotech threatening Pfizer’s grip on the Prevnar vaccine market - 6 months ago In the rapidly shrinking COVID market, this company still sees opportunity - 8 months ago Protein power: a biotech mining viruses to fight disease - 8 months ago A new delivery method muscling its way into the RNA space - over 1 year ago
6	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Gilead needs a win with Arcellx CAR-T data. Here’s how to know if it scores - 4 months ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Study: Researchers Detect Protein Behind the Spread of Shingles Virus - 6 months ago Bonding of RSV Prefusion F Proteins Display Potency Advantages - 11 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 7 months ago Celltrion Seeks Approval From FDA for CT-P47 as Biosimilar of Tocilizumab - about 1 year ago
9	JP Casey PV Tech In-depth PV news source. London, United Kingdom solar PVsupply chainin-depth news	Vikram Solar launches first HJT product, the Suryava module - 7 months ago
10	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Reporter Cell Line Development and Optimization for High Throughput Screening  - 7 months ago

Journalists covering ViroCell